Small cell lung cancer limited stage
Patients with small cell lung cancer (SCLC) will either be diagnosed in the limited or extensive stage of the disease. In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue. While the cancer may have spread to nearby lymph nodes or into the tissue between the lungs, the limited stage means that it has not metastasized to other organs in the body.
Due to the aggressive nature of small cell lung cancer, about 25 percent of patients are diagnosed with the disease in the limited stage. With a limited diagnosis, the median survival rate is about 16-24 months, with 14 percent at a 5-year survival rate.
Common treatments for limited-stage SCLC: For many people with limited-stage SCLC, surgery is typically not an option because the tumor is too large, or it has spread to adjacent lymph nodes or other areas of the lung. If the patient is in good health, the standard treatment is chemotherapy in addition to radiation. People who are too weak or in poor health and aren’t likely to tolerate chemotherapy and radiation together are often treated with chemotherapy alone, sometimes followed by radiation.
We also provide therapies to ease the symptoms that can be associated with SCLC, while improving your quality of life.